Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Smoking cessation lowers risk of AFib

Written by | 14 Sep 2024

Smoking cessation can significantly reduce a person’s risk of developing atrial fibrillation compared to those who continue smoking. Researchers reported this finding on Sept. 11 in JACC: Clinical… read more.

UCalgary study identifies a key role for pharmacists in stroke risk reduction

Written by | 7 Aug 2024

Atrial fibrillation (Afib) is the most common heart rhythm disorder encountered in clinical practice according to Dr. Roopinder Sandhu, MD, MPH, and the leading cause of stroke in… read more.

Affera Mapping and Ablation System with Sphere-9 catheter achieves endpoints for safety and efficacy, providing promising evidence for the future of atrial fibrillation treatment – Medtronic

Written by | 31 May 2024

Medtronic plc , announced positive results demonstrating excellent safety and efficacy of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one pulsed field (PF) and radiofrequency… read more.

Safety of switching from a Vitamin K antagonist to a non–Vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation

Written by | 8 May 2024

FRAIL-AF trial investigators set out to study the question of whether frail, elderly patients with atrial fibrillation who were doing well with vitamin K antagonists (VKA) should be… read more.

Engaging pharmacists to improve atrial fibrillation care

Written by | 26 Apr 2024

Atrial fibrillation, or AFib, is the most common type of irregular heartbeat, estimated to affect about 12.1 million U.S. adults by 2030.[1] The abnormal firing of electrical impulses causes… read more.

Atrial fibrillation linked to sweetened beverage use

Written by | 10 Mar 2024

Adults who consume two liters (about 67 ounces) or more of sugar- or artificially sweetened drinks per week are at a significantly higher risk of developing atrial fibrillation,… read more.

CE Mark for Varipulse Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation – Biosense Webster (J&J)

Written by | 7 Mar 2024

Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech, announced European CE mark approval of the Varipulse Platform for the… read more.

Late-breaking data from inspIRE and admIRE clinical trials for Varipulse Platform presented at AF Symposium – Biosense Webster J&J

Written by | 10 Feb 2024

Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi, announced 12-month results from the company-sponsored inspIRE study , “Predictors of… read more.

FDA approval for Farapulse pulsed field ablation system – Boston Scientific

Written by | 3 Feb 2024

Boston Scientific Corporation announced it has received FDA approval for the Farapulse Pulsed Field Ablation (PFA) System. The Farapulse PFA System is indicated for the isolation of pulmonary… read more.

FDA approval for PulseSelect Pulsed Field Ablation (PFA) system for the treatment of both paroxysmal and persistent atrial fibrillation – Medtronic

Written by | 17 Dec 2023

Medtronic plc announced that the FDA has approved the PulseSelect Pulsed Field Ablation (PFA) System for the treatment of both paroxysmal and persistent atrial fibrillation (AF). This is… read more.

Clinical smart watch finds success at identifying atrial fibrillation

Written by | 4 Dec 2023

As the use of wearable technology grows, smart watches are marketed across the globe to consumers as a way to monitor health. For some, they’re told by these… read more.

Catheter ablation shows promise in end-stage heart failure with atrial fibrillation

Written by | 28 Aug 2023

Some patients with end-stage heart failure and atrial fibrillation appear to respond significantly and positively to combination catheter ablation and guideline-directed medical therapy. Investigators reported their findings on… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.